3644 results for «2900»
3644 results
Getting started with a renal denervation programme
20 May 2025 – From EuroPCR 2025
Begin your renal denervation program with this comprehensive session focusing on the importance of a multidisciplinary hypertension team, procedural techniques with current devices, and expected clinical outcomes across patient subgroups. Practical case examples illustrate effective team-based hypertension management and procedural execution.
Why should laser atherectomy be part of your complex PCI algorithm?
21 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...
TAVI in patients with a small annulus
20 May 2025 – From EuroPCR 2025
Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.
Optimising CTO outcomes by lesion selection
21 May 2025 – From EuroPCR 2025
Optimize chronic total occlusion (CTO) PCI outcomes through lesion selection strategies. This session reviews coronary calcium patterns via CT, target vessel considerations, distal vessel remodeling, imaging-guided versus conventional approaches, and complex lesion cases.
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction
21 May 2025 – From EuroPCR 2025
Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...
New technology for transcather valve replacement - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a series of recorded cases showcasing advanced valve therapies and innovative techniques:
- A 70-year-old man with Marfan syndrome (treated by Bentall and CABG in 2012), impaired LV function (35%), CRT-D, and symptomatic severe primary MR (A2 prolapse with calcification) underwent implantation of an Intrepid valve under...
Post-procedure complications: leaflet thrombus, hemolytic anemia & more
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...
M-TEER for secondary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.
Mitral complications
08 Feb 2025 – From PCR Tokyo Valves 2025
High-risk TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Dive into this comprehensive TAVI session to explore various techniques and strategies for optimizing procedural outcomes. Discover how to align commissures in self-expandable valves, manage sudden deterioration in severe aortic stenosis without pre-operative evaluation, and tackle the unique challenges of rescue TAVI for cardiogenic shock. Additionally,...
Mitral valve-in-valve and valve-in-ring electrosurgery
08 Feb 2025 – From PCR Tokyo Valves 2025
Valve-in-valve
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this comprehensive session on valve-in-valve procedures, covering a wide range of complex scenarios. Gain insights into the first TAVR in a surgically implanted aortic Trifecta valve, TAVI-valve-in-valve double chimney stenting, transcatheter aortic valve replacement in a surgical aortic valve for bioprosthetic valve dysfunction, valve-in-valve for...
Mastering TAV-in-SAV: strategies, challenges and advanced techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to master the ins and outs of TAV-in-SAV? Don’t miss these presentations!
You’ll get expert guidance on evaluating feasibility, choosing the right transcatheter valve and using advanced techniques (valve fracture, leaflet modification, coronary protection...). Plus, you'll dive into multiple real-world case presentations that tackle challenges, share...
Repeat TAVI
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the world of repeat TAVI in this insightful session. Gain a comprehensive understanding of the predicted surge in valve-in-valve volume, the various causes of TAVI dysfunction requiring re-intervention, and the comparative performance of balloon-expandable and self-expandable valves for percutaneous treatment of failed aortic valve...
Mitral and tricuspid intervention
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in mitral and tricuspid valve interventions in this comprehensive session. Gain insights into the impact of respiratory dysfunction on mid-term clinical outcomes after M-TEER, the improvements in left atrial structure and function after mitral valve transcatheter edge-to-edge repair, and the use of...
TAVI challenging cases
09 Feb 2025 – From PCR Tokyo Valves 2025
Delve into this session showcasing challenging TAVI cases and innovative solutions. Witness a successful TAVI case with immediate valve implantation following BAV in a severely calcified aortic valve. Explore a case where VR simulation helped enable easier coronary access during PCI after TAVI. Discover the management...
Mitral valve interventions cases
09 Feb 2025 – From PCR Tokyo Valves 2025
This session delves into the latest advancements in minimally invasive mitral valve interventions. Explore a range of cutting-edge techniques, including 4D intracardiac echocardiography-guided mitral valve-in-valve procedures, valve-in-ring for severe mitral stenosis, pre-emptive tip to base LAMPOON in valve-in-ring TMVR, and chordal mapping with live multi-planar reconstruction...
